The voltage-gated proton channel hHv1 is functionally expressed in human chorion-derived mesenchymal stem cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 04 2020
28 04 2020
Historique:
received:
17
12
2019
accepted:
01
04
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
1
12
2020
Statut:
epublish
Résumé
The voltage-gated proton channel Hv1 is widely expressed, among others, in immune and cancer cells, it provides an efficient cytosolic H
Identifiants
pubmed: 32346069
doi: 10.1038/s41598-020-63517-3
pii: 10.1038/s41598-020-63517-3
pmc: PMC7188850
doi:
Substances chimiques
HVCN1 protein, human
0
Ion Channels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7100Références
Si, Y. L., Zhao, Y. L., Hao, H. J., Fu, X. B. & Han, W. D. MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res. Rev. 10, 93–103, https://doi.org/10.1016/j.arr.2010.08.005 (2011).
doi: 10.1016/j.arr.2010.08.005
pubmed: 20727988
Tokcaer-Keskin, Z. et al. Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies. Can. J. Physiol. Pharmacol. 87, 143–150, https://doi.org/10.1139/Y08-111 (2009).
doi: 10.1139/Y08-111
pubmed: 19234578
Talwadekar, M. D., Kale, V. P. & Limaye, L. S. Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study. Sci. Rep. 5, 15784, https://doi.org/10.1038/srep15784 (2015).
doi: 10.1038/srep15784
pubmed: 26507009
pmcid: 4623529
Han, Y. et al. Mesenchymal Stem Cells for Regenerative Medicine. Cells 8, https://doi.org/10.3390/cells8080886 (2019).
Li, H. et al. Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering. Stem Cell Int. 2019, 9671206, https://doi.org/10.1155/2019/9671206 (2019).
doi: 10.1155/2019/9671206
Zhang, R. et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J. Neuroinflammation 10, 106, https://doi.org/10.1186/1742-2094-10-106 (2013).
doi: 10.1186/1742-2094-10-106
pubmed: 23971414
pmcid: 3765323
Weiss, A. R. R. & Dahlke, M. H. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs. Front. Immunol. 10, 1191, https://doi.org/10.3389/fimmu.2019.01191 (2019).
doi: 10.3389/fimmu.2019.01191
pubmed: 31214172
pmcid: 6557979
Shi, Y. et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat. Rev. Nephrol. 14, 493–507, https://doi.org/10.1038/s41581-018-0023-5 (2018).
doi: 10.1038/s41581-018-0023-5
pubmed: 29895977
Wang, M., Yuan, Q. & Xie, L. Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application. Stem Cell Int. 2018, 3057624, https://doi.org/10.1155/2018/3057624 (2018).
doi: 10.1155/2018/3057624
Sundelacruz, S., Levin, M. & Kaplan, D. L. Comparison of the depolarization response of human mesenchymal stem cells from different donors. Sci. Rep. 5, 18279, https://doi.org/10.1038/srep18279 (2015).
doi: 10.1038/srep18279
pubmed: 26658512
pmcid: 4677319
Kaveh, K., Ibrahim, R., Abu Bakar, M. Z. & Ibrahim, T. A. Mesenchymal Stem Cells, Osteogenic Lineage and Bone Tissue Engineering: A Review. J. Anim. Veterinary Adv. 10, 2317–2330 (2011).
doi: 10.3923/javaa.2011.2317.2330
Luan, X., Li, G., Wang, G., Wang, F. & Lin, Y. Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34(+) cells: a comparison with human bone marrow-derived mesenchymal stem cells. Tissue Cell 45, 32–38, https://doi.org/10.1016/j.tice.2012.09.002 (2013).
doi: 10.1016/j.tice.2012.09.002
pubmed: 23107983
Wang, W. et al. Mesenchymal stem cells recruited by active TGFbeta contribute to osteogenic vascular calcification. Stem Cell Dev. 23, 1392–1404, https://doi.org/10.1089/scd.2013.0528 (2014).
doi: 10.1089/scd.2013.0528
Rustad, K. C. & Gurtner, G. C. Mesenchymal Stem Cells Home to Sites of Injury and Inflammation. Adv. Wound Care 1, 147–152, https://doi.org/10.1089/wound.2011.0314 (2012).
doi: 10.1089/wound.2011.0314
Sundelacruz, S., Levin, M. & Kaplan, D. L. Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS One 3, e3737, https://doi.org/10.1371/journal.pone.0003737 (2008).
doi: 10.1371/journal.pone.0003737
pubmed: 19011685
pmcid: 2581599
Heubach, J. F. et al. Electrophysiological properties of human mesenchymal stem cells. J. Physiol. 554, 659–672, https://doi.org/10.1113/jphysiol.2003.055806 (2004).
doi: 10.1113/jphysiol.2003.055806
pubmed: 14578475
Pillozzi, S. & Becchetti, A. Ion Channels in Hematopoietic and Mesenchymal Stem Cells. Stem Cells International, https://doi.org/10.1155/2012/217910 (2012).
Asuaje, A. et al. The inhibition of voltage-gated H+ channel (HVCN1) induces acidification of leukemic Jurkat T cells promoting cell death by apoptosis. Pflug. Arch. 469, 251–261, https://doi.org/10.1007/s00424-016-1928-0 (2017).
doi: 10.1007/s00424-016-1928-0
DeCoursey, T. E. Voltage-gated proton channels: molecular biology, physiology, and pathophysiology of the H(V) family. Physiol. Rev. 93, 599–652, https://doi.org/10.1152/physrev.00011.2012 (2013).
doi: 10.1152/physrev.00011.2012
pubmed: 23589829
pmcid: 3677779
El Chemaly, A. et al. VSOP/Hv1 proton channels sustain calcium entry, neutrophil migration, and superoxide production by limiting cell depolarization and acidification. J. Exp. Med. 207, 129–139, https://doi.org/10.1084/jem.20091837 (2010).
doi: 10.1084/jem.20091837
pubmed: 20026664
pmcid: 2812533
Ribeiro-Silva, L., Queiroz, F. O., da Silva, A. M., Hirata, A. E. & Arcisio-Miranda, M. Voltage-Gated Proton Channel in Human Glioblastoma Multiforme Cells. ACS Chem. Neurosci. 7, 864–869, https://doi.org/10.1021/acschemneuro.6b00083 (2016).
doi: 10.1021/acschemneuro.6b00083
pubmed: 27225904
Hondares, E. et al. Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells. Proc. Natl Acad. Sci. USA 111, 18078–18083, https://doi.org/10.1073/pnas.1411390111 (2014).
doi: 10.1073/pnas.1411390111
pubmed: 25425665
Eder, C. A mysterious channel: new insights into proton channel functioning raise new questions. J. Physiol. 586, 2419–2420, https://doi.org/10.1113/jphysiol.2008.154625 (2008).
doi: 10.1113/jphysiol.2008.154625
pubmed: 18480383
pmcid: 2464341
Wu, L. J. Voltage-gated proton channel HV1 in microglia. Neuroscientist 20, 599–609, https://doi.org/10.1177/1073858413519864 (2014).
doi: 10.1177/1073858413519864
pubmed: 24463247
El Chemaly, A., Nunes, P., Jimaja, W., Castelbou, C. & Demaurex, N. Hv1 proton channels differentially regulate the pH of neutrophil and macrophage phagosomes by sustaining the production of phagosomal ROS that inhibit the delivery of vacuolar ATPases. J. Leukoc. Biol. 95, 827–839, https://doi.org/10.1189/jlb.0513251 (2014).
doi: 10.1189/jlb.0513251
pubmed: 24415791
Capasso, M. et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat. Immunol. 11, 265–272, https://doi.org/10.1038/ni.1843 (2010).
doi: 10.1038/ni.1843
pubmed: 20139987
pmcid: 3030552
Schilling, T., Gratopp, A., DeCoursey, T. E. & Eder, C. Voltage-activated proton currents in human lymphocytes. J. Physiol. 545, 93–105, https://doi.org/10.1113/jphysiol.2002.028878 (2002).
doi: 10.1113/jphysiol.2002.028878
pubmed: 12433952
pmcid: 2290658
Smith, R. Y. et al. Voltage-gated proton channels exist in the plasma membrane of human oocytes. Hum. Reprod. 34, 1974–1983, https://doi.org/10.1093/humrep/dez178 (2019).
doi: 10.1093/humrep/dez178
pubmed: 31633762
Li, G., Miura, K. & Kuno, M. Extracellular phosphates enhance activities of voltage-gated proton channels and production of reactive oxygen species in murine osteoclast-like cells. Pflug. Arch. 469, 279–292, https://doi.org/10.1007/s00424-016-1931-5 (2017).
doi: 10.1007/s00424-016-1931-5
Kuno, M. et al. Acid-inducible proton influx currents in the plasma membrane of murine osteoclast-like cells. Pflug. Arch. 468, 837–847, https://doi.org/10.1007/s00424-016-1796-7 (2016).
doi: 10.1007/s00424-016-1796-7
Bernheim, L. et al. A voltage-dependent proton current in cultured human skeletal muscle myotubes. J. Physiol. 470, 313–333, https://doi.org/10.1113/jphysiol.1993.sp019860 (1993).
doi: 10.1113/jphysiol.1993.sp019860
pubmed: 7508503
pmcid: 1143919
Wang, Y., Wu, X., Li, Q., Zhang, S. & Li, S. J. Human voltage-gated proton channel hv1: a new potential biomarker for diagnosis and prognosis of colorectal cancer. PLoS One 8, e70550, https://doi.org/10.1371/journal.pone.0070550 (2013).
doi: 10.1371/journal.pone.0070550
pubmed: 23940591
pmcid: 3734282
Wang, Y. et al. Specific expression of the human voltage-gated proton channel Hv1 in highly metastatic breast cancer cells, promotes tumor progression and metastasis. Biochem. Biophys. Res. Commun. 412, 353–359, https://doi.org/10.1016/j.bbrc.2011.07.102 (2011).
doi: 10.1016/j.bbrc.2011.07.102
pubmed: 21821008
Cherny, V. V., Markin, V. S. & Decoursey, T. E. The Voltage-Activated Hydrogen-Ion Conductance in Rat Alveolar Epithelial-Cells Is Determined by the Ph Gradient. J. Gen. Physiol. 105, 861–896, https://doi.org/10.1085/jgp.105.6.861 (1995).
doi: 10.1085/jgp.105.6.861
pubmed: 7561747
DeCoursey, T. E. & Cherny, V. V. Temperature dependence of voltage-gated H+ currents in human neutrophils, rat alveolar epithelial cells, and mammalian phagocytes. J. Gen. Physiol. 112, 503–522, https://doi.org/10.1085/jgp.112.4.503 (1998).
doi: 10.1085/jgp.112.4.503
pubmed: 9758867
pmcid: 2229433
Kuno, M. et al. Temperature dependence of proton permeation through a voltage-gated proton channel. J. Gen. Physiol. 134, 191–205, https://doi.org/10.1085/jgp.200910213 (2009).
doi: 10.1085/jgp.200910213
pubmed: 19720960
pmcid: 2740922
Musset, B. et al. Zinc inhibition of monomeric and dimeric proton channels suggests cooperative gating. J. Physiol. 588, 1435–1449, https://doi.org/10.1113/jphysiol.2010.188318 (2010).
doi: 10.1113/jphysiol.2010.188318
pubmed: 20231140
pmcid: 2876801
Ramsey, I. S., Moran, M. M., Chong, J. A. & Clapham, D. E. A voltage-gated proton-selective channel lacking the pore domain. Nature 440, 1213–1216, https://doi.org/10.1038/nature04700 (2006).
doi: 10.1038/nature04700
pubmed: 16554753
pmcid: 4084761
Hong, L., Kim, I. H. & Tombola, F. Molecular determinants of Hv1 proton channel inhibition by guanidine derivatives. Proc. Natl Acad. Sci. USA 111, 9971–9976, https://doi.org/10.1073/pnas.1324012111 (2014).
doi: 10.1073/pnas.1324012111
pubmed: 24912149
Zhao, R. M. et al. Role of human Hv1 channels in sperm capacitation and white blood cell respiratory burst established by a designed peptide inhibitor. P Natl Acad. Sci. USA 115, E11847–E11856, https://doi.org/10.1073/pnas.1816189115 (2018).
doi: 10.1073/pnas.1816189115
Kawanabe, A. & Okamura, Y. Effects of unsaturated fatty acids on the kinetics of voltage-gated proton channels heterologously expressed in cultured cells. J. Physiol. 594, 595–610, https://doi.org/10.1113/JP271274 (2016).
doi: 10.1113/JP271274
pubmed: 26563684
pmcid: 5341712
Morgan, D. et al. Sustained activation of proton channels and NADPH oxidase in human eosinophils and murine granulocytes requires PKC but not cPLA2 alpha activity. J. Physiol. 579, 327–344, https://doi.org/10.1113/jphysiol.2006.124248 (2007).
doi: 10.1113/jphysiol.2006.124248
pubmed: 17185330
DeCoursey, T. E. & Cherny, V. V. Potential, pH, and arachidonate gate hydrogen ion currents in human neutrophils. Biophys. J. 65, 1590–1598, https://doi.org/10.1016/S0006-3495(93)81198-6 (1993).
doi: 10.1016/S0006-3495(93)81198-6
pubmed: 7506066
pmcid: 1225885
Wang, Y., Li, S. J., Wu, X., Che, Y. & Li, Q. Clinicopathological and biological significance of human voltage-gated proton channel Hv1 protein overexpression in breast cancer. J. Biol. Chem. 287, 13877–13888, https://doi.org/10.1074/jbc.M112.345280 (2012).
doi: 10.1074/jbc.M112.345280
pubmed: 22367212
pmcid: 3340163
Kumar, P., Nagarajan, A. & Uchil, P. D. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc 2018, https://doi.org/10.1101/pdb.prot095505 (2018).
Morgan, D., Cherny, V. V., Price, M. O., Dinauer, M. C. & DeCoursey, T. E. Absence of proton channels in COS-7 cells expressing functional NADPH oxidase components. J. Gen. Physiol. 119, 571–580 (2002).
doi: 10.1085/jgp.20018544
Robaszkiewicz, A. et al. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free. Radic. Biol. Med. 53, 1552–1564, https://doi.org/10.1016/j.freeradbiomed.2012.08.567 (2012).
doi: 10.1016/j.freeradbiomed.2012.08.567
pubmed: 22940495
Langenbach, F. & Handschel, J. Effects of dexamethasone, ascorbic acid and beta-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res. Ther. 4, 117, https://doi.org/10.1186/scrt328 (2013).
doi: 10.1186/scrt328
pubmed: 24073831
pmcid: 3854789
Balana, B. et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res. 16, 949–960, https://doi.org/10.1038/sj.cr.7310116 (2006).
doi: 10.1038/sj.cr.7310116
pubmed: 17160070
Pillozzi, S. & Becchetti, A. Ion channels in hematopoietic and mesenchymal stem cells. Stem Cell Int. 2012, 217910, https://doi.org/10.1155/2012/217910 (2012).
doi: 10.1155/2012/217910
Diehlmann, A. et al. KATP channels in mesenchymal stromal stem cells: strong up-regulation of Kir6.2 subunits upon osteogenic differentiation. Tissue Cell 43, 331–336, https://doi.org/10.1016/j.tice.2011.06.004 (2011).
doi: 10.1016/j.tice.2011.06.004
pubmed: 21820692
Zhang, Y. Y. et al. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells. J. Cell Physiol. 229, 202–212, https://doi.org/10.1002/jcp.24435 (2014).
doi: 10.1002/jcp.24435
pubmed: 23881642
Ding, F. et al. Involvement of cationic channels in proliferation and migration of human mesenchymal stem cells. Tissue Cell 44, 358–364, https://doi.org/10.1016/j.tice.2012.06.001 (2012).
doi: 10.1016/j.tice.2012.06.001
pubmed: 22771012
Tamas Kiss, E. Fa. H. K. Complexes of Aminophosphonates. II. Transition Metal Complexes of Aminophosphonic Acid Analogues of Aspartic Acid and Glutamic Acid. Inorganica Chim. Acts I55, 281–287 (1989).
doi: 10.1016/S0020-1693(00)90425-0
Cao, W., Cao, K., Cao, J., Wang, Y. & Shi, Y. Mesenchymal stem cells and adaptive immune responses. Immunol. Lett. 168, 147–153, https://doi.org/10.1016/j.imlet.2015.06.003 (2015).
doi: 10.1016/j.imlet.2015.06.003
pubmed: 26073566
Najar, M. et al. The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network. J. Immunother. 39, 45–59, https://doi.org/10.1097/CJI.0000000000000108 (2016).
doi: 10.1097/CJI.0000000000000108
pubmed: 26849074
de Castro, L. L., Lopes-Pacheco, M., Weiss, D. J., Cruz, F. F. & Rocco, P. R. M. Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J. Mol. Med. 97, 605–618, https://doi.org/10.1007/s00109-019-01776-y (2019).
doi: 10.1007/s00109-019-01776-y
pubmed: 30903229
Disthabanchong, S., Radinahamed, P., Stitchantrakul, W., Hongeng, S. & Rajatanavin, R. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int. 71, 201–209, https://doi.org/10.1038/sj.ki.5002035 (2007).
doi: 10.1038/sj.ki.5002035
pubmed: 17183249
Morgan, D., Cherny, V. V., Murphy, R., Katz, B. Z. & DeCoursey, T. E. The pH dependence of NADPH oxidase in human eosinophils. J. Physiol. 569, 419–431, https://doi.org/10.1113/jphysiol.2005.094748 (2005).
doi: 10.1113/jphysiol.2005.094748
pubmed: 16195320
pmcid: 1464255
D’Souza, N. et al. MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential. Adv. Biochem. Eng. Biotechnol. 130, 209–266, https://doi.org/10.1007/10_2012_150 (2013).
doi: 10.1007/10_2012_150
pubmed: 22990585
Karantalis, V. & Hare, J. M. Use of mesenchymal stem cells for therapy of cardiac disease. Circ. Res. 116, 1413–1430, https://doi.org/10.1161/CIRCRESAHA.116.303614 (2015).
doi: 10.1161/CIRCRESAHA.116.303614
pubmed: 25858066
pmcid: 4429294
Gong, Z. & Niklason, L. E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 22, 1635–1648, https://doi.org/10.1096/fj.07-087924 (2008).
doi: 10.1096/fj.07-087924
pubmed: 18199698
pmcid: 2605790
Shudo, Y. et al. Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering. Cytotherapy 18, 510–517, https://doi.org/10.1016/j.jcyt.2016.01.012 (2016).
doi: 10.1016/j.jcyt.2016.01.012
pubmed: 26971679
pmcid: 5964977
Oswald, J. et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cell 22, 377–384, https://doi.org/10.1634/stemcells.22-3-377 (2004).
doi: 10.1634/stemcells.22-3-377
Leach, J. K. & Whitehead, J. Materials-Directed Differentiation of Mesenchymal Stem Cells for Tissue Engineering and Regeneration. ACS Biomater. Sci. Eng. 4, 1115–1127, https://doi.org/10.1021/acsbiomaterials.6b00741 (2018).
doi: 10.1021/acsbiomaterials.6b00741
pubmed: 30035212
Murphy, M. B., Moncivais, K. & Caplan, A. I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 45, e54, https://doi.org/10.1038/emm.2013.94 (2013).
doi: 10.1038/emm.2013.94
pubmed: 24232253
pmcid: 3849579
Blair, H. C. et al. Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro. Tissue Eng. Part. B Rev. 23, 268–280, https://doi.org/10.1089/ten.TEB.2016.0454 (2017).
doi: 10.1089/ten.TEB.2016.0454
pubmed: 27846781
pmcid: 5467150
Xie, C. et al. The Emerging Role of Mesenchymal Stem Cells in Vascular Calcification. Stem Cell Int. 2019, 2875189, https://doi.org/10.1155/2019/2875189 (2019).
doi: 10.1155/2019/2875189
Wu, C. Y., Lu, G. L., Ji, M. & Wang, X. C. Effects of acidosis on the osteogenic differentiation of human bone marrow mesenchymal stem cell. Int. J. Clin. Exp. Med. 9, 23182–23189 (2016).
Fujita, H. et al. Necrotic and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro. Cell Biochem. Funct. 32, 77–86, https://doi.org/10.1002/cbf.2974 (2014).
doi: 10.1002/cbf.2974
pubmed: 23657822
Green, J., Yamaguchi, D. T., Kleeman, C. R. & Muallem, S. Cytosolic pH regulation in osteoblasts. Interaction of Na+ and H+ with the extracellular and intracellular faces of the Na+/H+ exchanger. J. Gen. Physiol. 92, 239–261, https://doi.org/10.1085/jgp.92.2.239 (1988).
doi: 10.1085/jgp.92.2.239
pubmed: 2844958
Redhead, C. R. & Baker, P. F. Control of intracellular pH in rat calvarial osteoblasts: coexistence of both chloride-bicarbonate and sodium-hydrogen exchange. Calcif. Tissue Int. 42, 237–242, https://doi.org/10.1007/bf02553749 (1988).
doi: 10.1007/bf02553749
pubmed: 3135089
Green, J., Yamaguchi, D. T., Kleeman, C. R. & Muallem, S. Cytosolic pH regulation in osteoblasts. Regulation of anion exchange by intracellular pH and Ca2+ ions. J. Gen. Physiol. 95, 121–145, https://doi.org/10.1085/jgp.95.1.121 (1990).
doi: 10.1085/jgp.95.1.121
pubmed: 2299328
DeCoursey, T. E. & Cherny, V. V. Voltage-activated proton currents in membrane patches of rat alveolar epithelial cells. J. Physiol. 489(Pt 2), 299–307, https://doi.org/10.1113/jphysiol.1995.sp021051 (1995).
doi: 10.1113/jphysiol.1995.sp021051
pubmed: 8847626
pmcid: 1156758
Fischer, H., Widdicombe, J. H. & Illek, B. Acid secretion and proton conductance in human airway epithelium. Am. J. Physiol-CellPh 282, C736–C743, https://doi.org/10.1152/ajpcell.00369.2001 (2002).
doi: 10.1152/ajpcell.00369.2001
Parekkadan, B. & Milwid, J. M. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87–117, https://doi.org/10.1146/annurev-bioeng-070909-105309 (2010).
doi: 10.1146/annurev-bioeng-070909-105309
pubmed: 20415588
pmcid: 3759519
Bonuccelli, G. et al. Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. Oncotarget 5, 7575–7588, https://doi.org/10.18632/oncotarget.2243 (2014).
doi: 10.18632/oncotarget.2243
pubmed: 25277190
pmcid: 4202145
Huang, W. H. et al. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene 32, 4343–4354, https://doi.org/10.1038/onc.2012.458 (2013).
doi: 10.1038/onc.2012.458
pubmed: 23085755
Melzer, C., Yang, Y. & Hass, R. Interaction of MSC with tumor cells. Cell Commun. Signal. 14, 20, https://doi.org/10.1186/s12964-016-0143-0 (2016).
doi: 10.1186/s12964-016-0143-0
pubmed: 27608835
pmcid: 5016940
Kansy, B. A. et al. The bidirectional tumor–mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res. Ther. 5, 95, https://doi.org/10.1186/scrt484 (2014).
doi: 10.1186/scrt484
pubmed: 25115189
pmcid: 4535379
Yang, Y., Otte, A. & Hass, R. Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines. Stem Cell Dev. 24, 1205–1222, https://doi.org/10.1089/scd.2014.0413 (2015).
doi: 10.1089/scd.2014.0413
Poggi, A., Musso, A., Dapino, I. & Zocchi, M. R. Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells. Immunol. Lett. 159, 55–72, https://doi.org/10.1016/j.imlet.2014.03.001 (2014).
doi: 10.1016/j.imlet.2014.03.001
pubmed: 24657523
Sun, Z., Wang, S. & Zhao, R. C. The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J. Hematol. Oncol. 7, 14, https://doi.org/10.1186/1756-8722-7-14 (2014).
doi: 10.1186/1756-8722-7-14
pubmed: 24502410
pmcid: 3943443
Norozi, F., Ahmadzadeh, A., Shahrabi, S., Vosoughi, T. & Saki, N. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells. Tumour Biol. 37, 11679–11689, https://doi.org/10.1007/s13277-016-5187-7 (2016).
doi: 10.1007/s13277-016-5187-7
pubmed: 27440203
Hong, I. S., Lee, H. Y. & Kang, K. S. Mesenchymal stem cells and cancer: friends or enemies? Mutat. Res. 768, 98–106, https://doi.org/10.1016/j.mrfmmm.2014.01.006 (2014).
doi: 10.1016/j.mrfmmm.2014.01.006
pubmed: 24512984
Su, P.et al. Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy. Int J Mol Sci 19, https://doi.org/10.3390/ijms19082343 (2018).
O’Malley, G. et al. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget 7, 60752–60774, https://doi.org/10.18632/oncotarget.11354 (2016).
doi: 10.18632/oncotarget.11354
pubmed: 27542276
pmcid: 5312417
Poggi, A. & Giuliani, M. Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment. Vaccines (Basel) 4, https://doi.org/10.3390/vaccines4040041 (2016).
Liotta, F. et al. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation. Br. J. Cancer 112, 745–754, https://doi.org/10.1038/bjc.2015.15 (2015).
doi: 10.1038/bjc.2015.15
pubmed: 25647013
pmcid: 4333504
Catacuzzeno, L. & Franciolini, F. Role of KCa3.1 Channels in Modulating Ca(2+) Oscillations during Glioblastoma Cell Migration and Invasion. Int J Mol Sci 19, https://doi.org/10.3390/ijms19102970 (2018).
Ruggieri, P. et al. The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells. PLoS One 7, e47825, https://doi.org/10.1371/journal.pone.0047825 (2012).
doi: 10.1371/journal.pone.0047825
pubmed: 23110108
pmcid: 3478269
Chimote, A. A. et al. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells. J. Immunol. 191, 6273–6280, https://doi.org/10.4049/jimmunol.1300702 (2013).
doi: 10.4049/jimmunol.1300702
pubmed: 24227782
pmcid: 4415878
Crottes, D. et al. Immature human dendritic cells enhance their migration through KCa3.1 channel activation. Cell Calcium 59, 198–207, https://doi.org/10.1016/j.ceca.2016.02.008 (2016).
doi: 10.1016/j.ceca.2016.02.008
pubmed: 27020659
Storck, H. et al. Ion channels in control of pancreatic stellate cell migration. Oncotarget 8, 769–784, https://doi.org/10.18632/oncotarget.13647 (2017).
doi: 10.18632/oncotarget.13647
pubmed: 27903970
Zavaczki, E. et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int. 80, 731–739, https://doi.org/10.1038/ki.2011.212 (2011).
doi: 10.1038/ki.2011.212
pubmed: 21716261
pmcid: 3257044